本網站使用瀏覽器紀錄 (Cookies) 來提供您最好的使用體驗，我們使用的 Cookie 也包括了第三方 Cookie。相關資訊請訪問我們的隱私權與 Cookie 政策。如果您選擇繼續瀏覽或關閉這個提示，便表示您已接受我們的網站使用條款。 關閉
TAIPEI, March 14, 2025 /PRNewswire/ -- Cordyceps Sunshine Biotech Holdings Co., Ltd. 【C.S Group】, in collaboration with the Chinese Herbal Fungi Industry Research and Development Association (CHFIRDA), hosted the "Pharmacological Applications of Taiwanofungus Camphoratus in the Pet Market" Seminar in Taipei. During the event, 【C.S Group】 officially announced its latest research findings, revealing that Antcin A, a purified extract from Taiwanofungus camphoratus, demonstrates potential synergistic effects with traditional steroids. The company is also exploring partnerships with premium pet food brands in China and plans to introduce exclusively supplied Taiwanofungus camphoratus extracts through its Greater China distributor, Guangdong Baoquan Agricultural Biotechnology, as part of its strategy to expand into the high-end pet food market. Accelerating Commercialization of Taiwanofungus Camphoratus-Based Pharmaceuticals Dr. Jia-Xin Huang, a leading expert in Taiwanofungus camphoratus, emphasized that developing new biopharmaceuticals traditionally requires extensive investment in animal and human trials, with no guarantee of success. However, Taiwanofungus camphoratus has already been extensively researched, providing a strong scientific foundation without needing to start from scratch. A key concern in previous discussions has been the long-term use of traditional steroids, which often leads to liver and kidney damage as a side effect. Taiwanofungus camphoratus is known for its liver- and kidney-protective properties, prompting further studies into its potential to reduce the adverse effects of steroids without compromising efficacy. To validate this hypothesis, 【C.S Group】 conducted an experiment combining its proprietary TF-15 Taiwanofungus camphoratus extract with the steroid dexamethasone (DXMS) in lung cancer cell models. The study confirmed: Genetic verification of TF-15 confirmed its authenticity 【C.S Group】as a Taiwanofungus camphoratus strain. TF-15 exhibits comparable potency to wood-cultivated Taiwanofungus camphoratus fruiting bodies. A high concentration of Antcin A was successfully extracted through a multi-stage purification process. The combination of Antcin A and dexamethasone showed potential synergistic effects in reducing and reversing cancer cell growth. Recognizing the regulatory and commercialization advantages of veterinary applications, 【C.S Group】 is prioritizing preclinical trials for pet medicine. The strategy includes: Establishing safe dosage and formulations for pets, such as oral solutions and chewable tablets. Accelerating human clinical trials by leveraging veterinary data. Expanding applications to both pet and human nutraceuticals, providing a flexible market strategy. This approach offers a balanced and strategic entry into the pharmaceutical sector, positioning Taiwanofungus camphoratus as a viable candidate for integrated pet and human health solutions. (Left) C.S Group Chief Technology Officer Vincent Liu; (Right) C.S Group Consultant Dr. Jia-Xin Huang. Pet Health Market Poised for Growth Vincent Liu, Chief Technology Officer at 【C.S Group】, highlighted the significant growth potential in China's pet market. As of 2024, China's pet population reached 124.1 million, with the pet food industry valued at $22.2 billion—including $9.8 billion in cat food and $10.3 billion in dog food. While mature markets like North America and Europe have penetration rates exceeding 90%, China's market penetration is still around 20%, signaling substantial room for growth. According to the China Feed Industry Association (CFIA), there are approximately 200 certified pet food manufacturers in China, with a total annual production capacity of 1.12 million tons. The market is shifting towards premium branding, creating opportunities for high-end functional pet foods. 【C.S Group】 is actively engaging with China's leading premium pet food brands and, through its Greater China distributor, Guangdong Baoquan Agricultural Biotechnology, plans to integrate Taiwanofungus camphoratus extracts into premium pet food formulations. Beyond pet nutrition, veterinary pharmaceuticals present another growth avenue. The global pet pharmaceutical market includes treatments for external and internal parasites, allergic dermatitis, anti-inflammatory pain relief, anti-nausea, insulin, antibiotics, and heart failure management. Given the broad-spectrum bioactivity of Taiwanofungus camphoratus, its potential therapeutic applications in pet medicine are highly promising. Leading the Market with Antcin A Mass Production Dalan Huang, President of 【C.S Group】, emphasized the importance of high-quality cultivation in ensuring premium product yields. He highlighted the company's commitment to optimizing Taiwanofungus camphoratus strain selection and mass production, enabling efficient extraction and purification of bioactive compounds for pharmaceutical applications. "The efficacy of Antcin A is well established in the industry, but the real question is: who has the capability to lead the market in large-scale extraction and production?" Huang stated. "Whoever masters the mass production of Taiwanofungus camphoratus extracts will control the next phase of the industry." While the company has ambitious goals, Huang stressed the importance of achievable milestones. Based on Dr. Jia-Xin Huang's preliminary findings, 【C.S Group】 has already made exciting progress and is optimistic that further optimization will lead to the development of the first batch of Taiwanofungus camphoratus-based veterinary pharmaceuticals. This breakthrough has the potential to accelerate commercialization and integration into the pet health industry. With scientific validation, strategic partnerships, and market positioning, 【C.S Group】 is advancing Taiwanofungus camphoratus from traditional applications to next-generation pharmaceuticals. As the global pet and human health industries continue to expand, the company is well-positioned to lead innovation in functional ingredients and biopharmaceutical applications.
New studies reveal that the three-strain Bacillus probiotic can better protect weaned piglets against diverse health challenges. SINGAPORE, March 11, 2025 /PRNewswire/ -- IFF (NYSE:IFF) today announced the extension of their three-strain Bacillus probiotic, Enviva® PRO, to pigs. By incorporating IFF's probiotic into their diet, producers will be better positioned to protect their animals against diverse health challenges. The extension of Enviva® PRO enhances IFF's robust portfolio of proven, cost-effective animal nutrition and health solutions that help customers optimize production, livability and profitability. "The weaning and post-weaning period can be extremely difficult to navigate for swine producers, so implementing a nutritional management strategy is crucial for improving their welfare and avoiding growth setbacks," said Dr. Ester Vinyeta, swine innovation lead at IFF. "In addition to the proven benefits of Enviva® PRO already experienced by broiler producers, swine producers now can have peace of mind that their litters have optimal gut health – helping them meet growing production demands." Post-weaning, piglets may face challenges like nutritional stress, reduced feed intake, and digestive health issues, which can impact performance. Enviva® PRO is proven to establish and maintain a favorable nutribiotic state that supports optimal gut function, leading to improved nutrient digestion and performance. Extensive studies performed by IFF found that compared to the control group, Enviva® PRO improved average daily weight gain by 2.5% and reduced diarrhea frequency by 6.3%. Enviva® PRO is currently available to swine producers across Japan and the US. IFF plans to extend availability to other territories following pending regulatory authorizations. Learn more about the benefits of Enviva® PRO and nutribiosis in animal production at animalnutrition.iff.com/enviva-pro. About Danisco Animal Nutrition & Health Danisco Animal Nutrition & Health, part of IFF, is an industry leader in nutritional health solutions with a comprehensive portfolio of feed enzymes, betaine, essential oils and probiotics. Through the lens of nutribiosis, IFF invests in science and innovation to help producers improve performance, increase liveability and support welfare in the face of increasing pressure to reduce or remove antibiotics from production systems. Danisco Animal Nutrition & Health capabilities are underpinned by the quality and quantity of our trials, including over 100,000 guts sampled from over 600 farms, investments in omics technologies and microbiome research, and collaboration with leading commercial, governmental and academic partners. For more information, visit iff.com/animal-nutrition. Welcome to IFF At IFF (NYSE: IFF), we make joy through science, creativity and heart. As the global leader in flavors, fragrances, food ingredients, health and biosciences, we deliver groundbreaking, sustainable innovations that elevate everyday products—advancing wellness, delighting the senses and enhancing the human experience. Learn more at iff.com, LinkedIn, Instagram and Facebook. ©2025 International Flavors & Fragrances Inc. (IFF). IFF, the IFF Logo, and all trademarks and service marks denoted with ™, SM or ® are owned by IFF or affiliates of IFF unless otherwise noted. All Rights Reserved.
INDIANAPOLIS, March 4, 2025 /PRNewswire/ -- The Indianapolis Prize, the world's leading award for animal conservation, has named Mwezi "Badru" Mugerwa the Winner of the 2025 Indianapolis Prize Emerging Conservationist Award. This honor—only the second given to date—is presented to a conservationist under 40 who has made a significant impact on saving an animal species or group of species. Mugerwa will receive a $50,000 award. Mugerwa is a Ugandan conservationist and researcher and is the founder and director of Embaka, a grassroots community-based conservation organization focused on the preservation of the African golden cat. He established the first-ever community-based anti-poaching conservation project focused on the African golden cat at Bwindi Impenetrable Forest National Park in Uganda. Mugerwa also created the African Golden Cat Conservation Alliance (AGCCA), a network of African nationals implementing conservation activities for the African golden cat across the species range. Additionally, Mugerwa serves as the president of the Society for Conservation Biology's Africa Region and is the president-elect for the Society for Conservation Biology Global. "Mwezi's passion for involving the local community in conservation efforts is what makes him so worthy of receiving this award. It is a distinct honor to recognize him as the 2025 Indianapolis Prize Emerging Conservationist," said Dr. Rob Shumaker, president and CEO of the Indianapolis Zoological Society. Mugerwa began studying the African golden cat through research using camera traps, where he captured a black and white image of an unknown animal in the forest. At the time, the African golden cat was virtually unknown—an elusive species found only in the forests of equatorial Africa. Turning to the community, he came to understand how the wild cat's primary threat—poaching—was directly connected to the livelihood of local people, as it is often caught in bushmeat snares. Since its founding in 2015, Embaka has focused on involving the community in conservation efforts. Through four programs—offering everything from free oral health care and livestock, to helping with credit and savings for families in exchange for a pledge not to poach—more than 2,225 community members have registered to support the African golden cat. "Having a national park in your backyard is not a burden, it's an opportunity. That's the connection we've been trying to draw for the African golden cat in these communities," said Mugerwa. "Once you're in the communities and you understand the problem: 'I need money to pay my dentist bills.' Well, what if I brought you a dentist? Once you explain that, it connects really well. The communities hold the solutions, but if you don't talk to them, you won't know." Using artificial intelligence to analyze camera trap data, Mugerwa and others working with the AGCCA in 19 African countries are moving toward a standardized model of observation to better study the population of African golden cats across the continent. Mugerwa was chosen through a two-stage selection process and was named one of 10 Finalists in October 2024. The Emerging Conservationist award is made possible through a gift from the Kobe Foundation. In May, the Indianapolis Prize will also announce the 2025 Indianapolis Prize Winner, who will receive a $250,000 award for their work in animal species conservation. The Indianapolis Prize Winner and Indianapolis Prize Emerging Conservationist will be honored at the Indianapolis Prize Gala on Sept. 27, 2025, presented by Cummins Inc., in downtown Indianapolis. For additional media assets for the 2025 Indianapolis Prize Emerging Conservationist Award, click here. To learn more about the previous Indianapolis Prize Winners, visit IndianapolisPrize.org. About the Indianapolis Prize The Indianapolis Prize recognizes and rewards conservationists who have achieved major victories in advancing the sustainability of an animal species or group of species. The Emerging Conservationist Award, a newly established accolade in 2023, is given to a conservationist age 40 or younger. Since 2004, the Indianapolis Prize has awarded more than $7 million in unrestricted cash awards, advancing the work of conservation scientists through financial support and public awareness. The Indianapolis Prize is a conservation initiative of the Indianapolis Zoological Society, Inc. Connect with the Prize on Facebook, X, Instagram and indianapolisprize.org. Media Contacts Alliy MoyerConservation PR Specialist317-630-3265amoyer@indyzoo.com Camille PipinoVOX Global614-588-6488cpipino@voxglobal.com
LOS ANGELES, Feb. 28, 2025 /PRNewswire/ -- SONGMICS HOME, a global online furnishings brand serving 20 million families, today announced its social responsibility commitment with the S-HOME Initiative, a cross-border welfare program delivering positive impact through the principles of "Support. Share. Sustain." Since its inception, the initiative has partnered with several local NGOs across the United States, Germany, and France to drive impact in social care, animal welfare, disaster relief, and sustainable development. Looking ahead, SONGMICS HOME aims to extend its 'Complete Your Dream Home' mission into broader societal frameworks through sustained S-HOME engagement. S-HOME Initiative 2025 Video-By SONGMICS HOME Social Care Through multi-year partnerships, SONGMICS HOME empowered vulnerable groups across continents: In France, sustained donations to Emmaüs Défi (one of France's leading charities supporting the underprivileged) provided home essentials for low-income families alongside annual charity events. U.S. collaborations with Rise Above Foundation (a U.S. non-profit organization dedicated to empowering foster youths to live independently) transformed transitional housing for foster care alumni, while Germany's Jugendrotkreuz (Youth Red Cross) partnership enhanced youth emergency preparedness through sponsored offline training events. Animal Welfare The initiative delivered cross-species impact via strategic alliances—supporting Priceless Pets Rescue (a U.S.-based nonprofit animal welfare organization)'s adoption drives with product donations from 2022, while providing France's Société Protectrice des Animaux (SPA, one of the oldest French animal welfare organizations) rescue centers supplies and medications from 2023 to 2024. Disaster Aid In response to the 2023 earthquakes in Turkey, SONGMICS HOME provided emergency supplies including camp beds and picnic mats to affected regions, delivering practical support during the crisis recovery phase. Sustainable Development SONGMICS HOME planted 18,000+ trees globally in 2023 through its partnership with One Tree Planted (a global non-profit organization dedicated to reforestation and environmental conservation), directly contributing to international reforestation projects. "True sustainability thrives when business innovation intersects with community commitment. Through these cross-sector partnerships, we're building a legacy where every product sold actively contributes to a brighter, sustainable, and thriving future." Daisy Wei, Senior Brand Manager at SONGMICS HOME, emphasized the meaning of S-HOME Initiative. About SONGMICS HOME SONGMICS HOME was officially established in 2010. We own 3 major product brands including SONGMICS for home furnishings, VASAGLE for stylish furniture, and Feandrea for pet supplies. With the mission of "Complete Your Dream Home", we strive to provide global consumers with stylish and valuable furnishing products. Together with an efficient experience, we are enabling everyone to effortlessly create their dream homes. To date, our products have successfully entered more than 70 countries and regions, including Europe, North and Central America, and Asia, serving over 20 million families worldwide. Media Contact: pr@songmicshome.com
Mars announces intention to undertake world's largest international study program into the human-animal bond and the role of cats and dogs in human mental health and wellbeing The multi-year research program in partnership with leading academics will span over 35,000 people across more than 20 countries. It launches at a time of growing awareness of the global mental health crisis affecting millions1,2 Mars also unveils unique research and content partnership with Calm, a leading mental health company, to shine a light on pets and their role in human mental health and wellbeing BRUSSELS, Feb. 21, 2025 /PRNewswire/ -- Mars, Incorporated – the leading pet care business – has announced the launch of the Pets and Wellbeing Study (PAWS) program. PAWS is set to become the world's largest, multi-year research program exploring the impact of cats and dogs on mental health and wellbeing, deepening our understanding of the mutual benefits of the human-animal bond. Pet owner and their cat bonding: Mars launches landmark global study into the human-animal bond Led by the Waltham Petcare Science Institute in collaboration with leading academic institutions and experts, PAWS will examine the connection between pets and human mental health and wellbeing (including stress, anxiety, loneliness and overall wellbeing). The multi-disciplinary research program will engage over 35,000 people across 20+ countries in the initial phase and will continue to build over time. The program aims to bring deeper insight and scientific data into the mutual benefits of the human-animal bond, including how pets may enrich lives and how the bond contributes to the life of pets. Loïc Moutault, President of Mars Petcare, said: "As a pet owner, I know firsthand the joy and comfort pets bring to our lives and there is increasing evidence that owning a pet or simply interacting with one can bring benefits to people of all ages and from all walks of life. We're aiming to deliver on our Purpose: A Better World for Pets, because we believe pets make our lives better, and through this study program we aim to provide deeper, science-backed understanding of the mutual bond between people and pets." Over the lifetime of the study program the collaborative research will include work with academic institutions and partners including Cummings School of Veterinary Medicine at Tufts University, University of Maryland School of Nursing, University of Pennsylvania School of Veterinary Medicine, University of Liverpool, University of Arizona College of Veterinary Medicine, YouGov and the Human Animal Bond Research Institute, with the aim to deliver novel research and new insights. Dr Maggie O'Haire, Associate Dean for Research at the University of Arizona College of Veterinary Medicine said: "Both the breadth and depth of this study program promise to deliver novel data and greater insight into something many people instinctively feel – that the bond between pet and pet owner is a powerful and unique part of the human experience. We are proud to continue to collaborate with Mars and its world-leading research institute as it embarks on this transformative work." As part of the program, Mars is also partnering with Calm, a leading mental health company. The collaboration combines Calm's expertise in mental wellness with Mars' leading research into the human-animal bond and will encompass research and content through 2025. Dr. Chris Mosunic, Chief Clinical Officer, Calm said: "Pets are daily sources of calm, joy, and connection. Through our partnership with Mars, we aim to understand these relationships better and illuminate the unique role pets play in mental health and wellbeing, supported by new in-app resources." Wellbeing has become an increasingly vital priority with 45% of people across 31 countries identifying mental health as their top health concern.2 At the same time, global anxiety and stress levels are rising, affecting over 301 million people worldwide.1 A growing body of evidence shows that pets can have a positive impact on mental health, underscoring the powerful potential of human-animal interaction to enhance wellbeing.3,4 With 56% of people worldwide owning pets and a global pet population of 1 billion, understanding the universal and transformative bond between humans and animals has never been more important.3 Mars advocates for the essential role companion animals play in our lives and is committed to tackling issues such as pet homelessness to keep pets and people together. Over the next five years, Mars aims to support millions of vulnerable pets worldwide alongside a coalition of dedicated partners and believes a deeper understanding of the role pets play in people's lives will contribute to improving the lives of pets and the people who care for them. Mars is a global leader in pet care, spanning comprehensive veterinary care (including: AniCura, BANFIELD™, BLUEPEARL™, Linnaeus and VCA™), nutrition (including PEDIGREE®, ROYAL CANIN®, and WHISKAS®), breakthrough programs in veterinary diagnostics (ANTECH®), wearable health monitoring and pet parent platforms. With over 100,000 Associates helping pets, their owners and pet professionals in more than 130 countries. For more information on PAWS program, visit: www.mars-petsandwellbeing.com About Mars, Incorporated Mars, Incorporated is driven by the belief that the world we want tomorrow starts with how we do business today. As a $50bn+ family-owned business, our diverse and expanding portfolio of leading pet care products and veterinary services support pets all around the world and our quality snacking and food products delight millions of people every day. We produce some of the world's best-loved brands including ROYAL CANIN®, PEDIGREE®, WHISKAS®, CESAR®, DOVE®, EXTRA®, M&M's®, SNICKERS® and BEN'S ORIGINAL™. Our international networks of pet hospitals, including BANFIELD™, BLUEPEARL™, VCA™ and ANICURA™ span preventive, general, specialty, and emergency veterinary care, and our global veterinary diagnostics business ANTECH® offers breakthrough capabilities in pet diagnostics. The Mars Five Principles — Quality, Responsibility, Mutuality, Efficiency and Freedom — inspire our 150,000 Associates to act every day to help create a better world for people, pets and the planet. For more information about Mars, please visit www.mars.com. Join us on Facebook, Instagram, LinkedIn and YouTube. About Waltham Petcare Science Institute Waltham Petcare Science Institute has been advancing pet health and nutrition for more than 60 years. Today, we research new ways to predict, manage and prevent disease, discovering insights and advances that proactively help pets live happier, healthier lives. Waltham collaborates with leading external scientific experts and partners to drive innovation creating a better world for pets based on scientific evidence. Building on a strong legacy of human-animal interaction research, we continue to advance scientific understanding of the relationships between pets and people. For more information, visit: www.waltham.com. Join us on LinkedIn. About Calm Calm is a consumer mental health company on a mission to support everyone on every step of their mental health journey. With the #1 app to help you sleep more, stress less and live mindfully as well as a growing library of digital, evidence-based mental health programs, Calm offers trusted support for individuals and organizations alike. Our flagship consumer app provides personalized content and activities – featuring a range of experts and beloved celebrity voices. Our workplace and healthcare solutions take a consumer-friendly approach to mental health support delivered on a HIPAA-compliant platform to drive positive health and business outcomes. Named a TIME100 Most Influential Company, Calm has more than 150 million downloads and supports more than 3,500 organizations across seven languages and 190 countries. To learn more, visit calm.com. References World Health Organization, Anxiety Disorders, 2023 IPSOS, Ipsos Health Service Report 2024: Mental Health seen as the biggest Health issue, 2024 Mars, Mars Global Pet Parent Study, 2024 Gitanjali E. Gnanadesikan et al. Glucocorticoid response to naturalistic interactions between children and dogs. Hormones and Behavior. Volume 161, May 2024 Pet owner and their dog: Mars announces plans for world’s largest international study program into the role of cats and dogs in human mental health and wellbeing
NEW YORK, Feb. 20, 2025 /PRNewswire/ -- Tuya Smart (NYSE: TUYA, HKEX: 2391), a global cloud platform service provider, today announced the integration of its AIoT platform with cutting-edge AI models including DeepSeek. By leveraging advanced technologies like natural language processing (NLP) and multimodal scene perception, Tuya is driving the transformation of smart devices into "active intelligence," paving the way for AI applications to reach their full potential. This announcement comes during a current wave of AI technology competition worldwide, which showcases numerous commercial possibilities in fields such as energy management, pet care, emotional companionship, and smart homes. However, the commercialization of AI technology still faces many challenges. According to Gartner, more than 80% of AI projects fail to progress beyond the lab due to a lack of end-to-end deployment capabilities and scenario-based solutions. To bridge the gap between AI algorithms and real-world commercialization, AIoT platforms are playing a crucial role in enabling seamless deployment. Tuya's deep integration with DeepSeek will have significant impact on the pet care industry through the synergy between Tuya's AIoT platform and DeepSeek's multimodal AI capabilities. These synergies will translate into tangible pet care innovations, and further accelerate the adoption of AI-driven solutions across the pet industry. Unlocking the "New World" of the Pet Economy with DeepSeek In recent years, the global pet economy has witnessed exponential growth. According to a 2024 report by Bloomberg Intelligence, the industry is projected to expand by over 45% within the next six years, with global revenues expected to surpass $500 billion by 2030. Despite this rapid growth, the market for smart pet products remains plagued by functional homogeneity. Many so-called "intelligent" devices are limited to basic monitoring features, such as tracking weight and food intake. However, when it comes to critical needs like pet health management, behavioral analysis, and interactive experiences, user satisfaction remains low. In one case, a pet owner noticed their pet had been lying on a smart mattress for three consecutive days, showing little movement. The device merely reported that the pet's "daily activity level did not meet the standard." It wasn't until the pet showed symptoms of rectal bleeding and was rushed to the hospital that it was diagnosed with gastroenteritis. In reality, the mattress's temperature sensor had already detected an abnormal rise in the pet's abdominal temperature—but failed to issue a timely alert. By integrating Tuya's Cloud Developer Platform with DeepSeek's advanced AI model, the pet industry will experience a fundamental shift from "single-device networking" to a fully interconnected, intelligent ecosystem. This transformation is accelerating innovation in pet care by enabling holistic, AI-driven scenarios, offering pet owners a more seamless, proactive, and worry-free experience. A Cognitive Leap in Pet Care The deep integration of Tuya's smart ecosystem and DeepSeek's advanced AI model is set to revolutionize the "perception" capabilities of smart pet products. By enabling AI-powered hardware to truly "understand" pets, this synergy is redefining the interaction between pets and their owners, ushering in a new era of intelligent pet care. Imagine a morning where the sunlight filters through the curtains, and a pet's smart collar quietly completes a health check. If it detects a 15% increase in breathing rate, it automatically triggers an "environmental temperature and humidity adjustment." If it notices a 70% decrease in the pet's usual scratching behavior, it flags "nail health requires attention." When a smart litter box detects abnormal fluctuations in urine pH, it instantly connects with the pet health management system, providing real-time emergency hospital navigation within a three-kilometer radius and generating a comprehensive seven-day diet and activity report for veterinarians. Meanwhile, if the owner is away and an intelligent pet camera detects repeated pacing near the entrance, the AI system springs into action. It plays a pre-recorded, reassuring voice message from the owner, dispenses freeze-dried treats infused with calming ingredients, and sends a notification to the owner's phone: "Separation anxiety detected. A soothing plan has been initiated. Consider increasing exercise by 30% during tonight's walk." By transforming passive monitoring into proactive care, Tuya and DeepSeek are setting a new standard for AI-driven pet wellness, making pet ownership more intuitive, seamless, and stress-free. Envisioning the Future of Pet AI Hardware The deep reasoning capabilities of DeepSeek's AI model are poised to shatter the rigid, mechanical logic of traditional smart hardware, ushering in a new era of AI-driven innovation. The transformation of the pet industry will be profound. AI devices will soon be able to detect subtle emotional cues, identifying hidden anxiety from the frequency of a pet licking its food bowl or predicting excitement based on the curvature of its tail movement. This evolution from mere command execution to deep emotional perception signals that AI hardware is steadily acquiring human-like cognitive abilities. To inspire the next generation of AI-powered pet technology, Tuya and DeepSeek have envisioned groundbreaking possibilities for future pet AI hardware. Through the insights of large-scale AI models, these innovations could redefine the very boundaries of pet technology: Brainwave Translation Collar: Traditional smart devices often misinterpret a pet's unusual behavior as mere mischief, failing to grasp its true emotional state. This collar, however, captures and analyzes a pet's brainwave signals in real time, converting them into an intuitive emotional spectrum. Pet owners can then "read" their furry companion's emotions via a mobile app, receiving personalized care recommendations tailored to their pet's state of mind. Dream Projector: When a pet exhibits abnormal brainwave activity at night, an AI-driven projector near its bed quietly activates, transforming the wall into an immersive dream world. Each morning, owners receive detailed dream reports, complete with insights such as "Last night's happiness index: 92, energy expenditure: 35%." This breakthrough compensates for the limitations of traditional monitoring devices, which often fail to capture a pet's nighttime behavior and well-being. AI Gene Feeder: By integrating advanced DNA analysis, this feeder dynamically formulates meals tailored to a pet's unique genetic profile, optimizing nutrition in real time. When illness is detected, the feeder functions as an intelligent pharmacist, seamlessly embedding medication into flavored gel capsules to ensure smooth and stress-free ingestion. With this innovation, pet food manufacturers can address common nutritional deficiencies in standardized diets while unlocking new opportunities in the pet health market. Odor Socializer: Urbanization has led to an increase in social deprivation among pets, leaving many owners searching for ways to enrich their companions' lives. This device recreates social interactions through AI, allowing pets to mark territory and engage with virtual companions using odor molecules. Simultaneously, it can identify and recommend like-minded playmates within a 500-meter radius, enabling pets to enjoy real-world socialization with compatible furry friends. By embedding DeepSeek's AI into the pet industry, Tuya is turning the pet tech sector into one of the most dynamic proving grounds for the AI revolution. This shift not only creates unprecedented opportunities for global developers but also fuels growing consumer expectations for the future of intelligent pet care.
A12 藝術空間
Animals/Pets
請先登入後才能發佈新聞。
還不是會員嗎？立即 加入台灣產經新聞網會員 ，使用免費新聞發佈服務。 （服務項目） （投稿規範）
